Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality

Abstract

Background: Extracorporeal membrane oxygenation is a cardiopulmonary supportive therapy. In this study, we reviewed our experience with extracorporeal membrane oxygenation support and tried to identify measurable values which might predict in-hospital mortality. Methods: From January 2004 through December 2008, 50 of 21,298 adult patients received venoarterial extracorporeal membrane oxygenation. We retrospectively analyzed clinical records of these 50 consecutive patients. Details of demographics, preoperative measurements, clinical characteristics at the time of extracorporeal membrane oxygenation implantation, extracorporeal membrane oxygenation-related complications and in-hospital mortality were collected. Logistic regression analyses were performed to investigate predictors of mortality. A p-value ≤ 0.05 was accepted as significant. Results: Thirty-eight patients were weaned from extracorporeal membrane oxygenation and 33 patients survived to discharge. The overall survival rate was 66%. In a multiple logistic regression analysis, blood lactate level before initiation of extracorporeal membrane oxygenation was a risk factor associated with in-hospital mortality (OR 1.27 95% CI 1.042-1.542). To evaluate the utility of the lactate in predicting mortality, a conventional receiver operating characteristic curve was produced. Sensitivity and specificity were optimal at a cut-off point of 12.6mmol/L, with an area under the curve of 0.752. The positive and negative predictive values were 73.3% and 83.9%, respectively. Conclusions: Extracorporeal membrane oxygenation is a justifiable alternative treatment for postoperative refractory cardiac and pulmonary dysfunction which could rescue more than sixty percent of otherwise fatal patients. Patients with pre-extracorporeal membrane oxygenation lactate levels above 12.6mmol/L are at higher risks for in-hospital death. Evidence-based therapy for this group of high risk patients is needed.

Keywords

Adult extracorporeal membrane oxygenation mortality complications lactate

Get full access to this article

View all access options for this article.

References

Gibbon JH Jr , Miller BJ , Dobell AR , Engell HC , Voigt GB The closure of interventricular septal defects in dogs during open cardiotomy with the maintenance of the cardiorespiratory functions by a pump-oxygenator. J Thorac Surg 1954; 28(3): 235-240.

Hill JD , O’Brien TG , Murray JJ , et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung . N Engl J Med 1972; 286(12): 629-634.

Muehrcke DD , McCarthy PM , Stewart RW , et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg 1996; 61(2): 684-691.

Magovern GJ Jr , Magovern JA , Benckart DH , et al. Extracorporeal membrane oxygenation: preliminary results in patients with postcardiotomy cardiogenic shock. Ann Thorac Surg 1994; 57(6): 1462-1468.

Zhao J. , Liu J. , Feng Z. , et al. Clinical outcomes and experience of 20 pediatric patients treated with extracorporeal membrane oxygenation in Fuwai Hospital. ASAIO J 2008; 54(3): 302-305.

Doll N. , Kiaii B. , Borger M. , et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004; 77(1): 151-157.

Ko WJ , Lin CY , Chen RJ , Wang SS , Lin FY , Chen YS Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002; 73(2): 538-545.

Bakhtiary F. , Keller H. , Dogan S. , et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008 ; 135(2): 382-388.

Zhang R. , Kofidis T. , Kamiya H. , et al. Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg 2006; 30(4): 617-20.

10.

Combes A. , Leprince P. , Luyt CE , et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36(5): 1404-1411.

11.

Zimpfer D. , Heinisch B. , Czerny M. , et al. Late vascular complications after extracorporeal membrane oxygenation support. Ann Thorac Surg 2006; 81: 892-895.

12.

Hemmila MR , Rowe SA , Boules TN , et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004; 240(4): 595-605.

13.

Kalyanaraman M. , DeCampli WM , Campbell AI , et al. Serial blood lactate levels as a predictor of mortality in children after cardiopulmonary bypass surgery. Pediatr Crit Care Med 2008 ; 9(3): 285-8.

14.

Maillet JM , Le Besnerais P. , Cantoni M. , et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest 2003; 123(5): 1361-6.

15.

Nguyen HB , Rivers EP , Knoblich BP , et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32: 1637-1642.

16.

Meyns B. , Vercaemst L. , Vandezande E. , et al. Plasma leakage of oxygenators in ECMO depends on the type of oxygenator and on patient variables. Int J Artif Organs 2005; 28(1): 30-34.